Enhancing the antitumor potency of T cells redirected by bispecific antibodies

Oncoscience. 2017 Oct 5;4(9-10):120-121. doi: 10.18632/oncoscience.366. eCollection 2017 Sep.

Authors

Chien-Hsing Chang¹, David M Goldenberg¹

Affiliation

¹ IBC Pharmaceuticals Inc., and Immunomedics Inc., Morris Plains, New Jersey, USA.

No abstract available

Keywords: CD3; T cells; Trop-2; bispecific antibody; immunotherapy.

Publication types

Editorial